• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N 结构域在哺乳动物 AAA ATPase p97/VCP 的 ATP 酶活性中的作用。

The role of the N-domain in the ATPase activity of the mammalian AAA ATPase p97/VCP.

机构信息

Centre for Structural Biology, Division of Molecular Biosciences, Faculty of Natural Sciences, Imperial College London, London SW7 2AZ, United Kingdom.

出版信息

J Biol Chem. 2012 Mar 9;287(11):8561-70. doi: 10.1074/jbc.M111.302778. Epub 2012 Jan 23.

DOI:10.1074/jbc.M111.302778
PMID:22270372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3318706/
Abstract

p97/valosin-containing protein (VCP) is a type II ATPase associated with various cellular activities that forms a homohexamer with each protomer containing an N-terminal domain (N-domain); two ATPase domains, D1 and D2; and a disordered C-terminal region. Little is known about the role of the N-domain or the C-terminal region in the p97 ATPase cycle. In the p97-associated human disease inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia, the majority of missense mutations are located at the N-domain D1 interface. Structure-based predictions suggest that such mutations affect the interaction of the N-domain with D1. Here we have tested ten major inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia-linked mutants for ATPase activity and found that all have increased activity over the wild type, with one mutant, p97(A232E), having three times higher activity. Further mutagenesis of p97(A232E) shows that the increase in ATPase activity is mediated through D2 and requires both the N-domain and a flexible ND1 linker. A disulfide mutation that locks the N-domain to D1 in a coplanar position reversibly abrogates ATPase activity. A cryo-EM reconstruction of p97(A232E) suggests that the N-domains are flexible. Removal of the C-terminal region also reduces ATPase activity. Taken together, our data suggest that the conformation of the N-domain in relation to the D1-D2 hexamer is directly linked to ATP hydrolysis and that the C-terminal region is required for hexamer stability. This leads us to propose a model where the N-domain adopts either of two conformations: a flexible conformation compatible with ATP hydrolysis or a coplanar conformation that is inactive.

摘要

p97/包含 valosin 的蛋白 (VCP) 是一种与各种细胞活动相关的 II 型 ATP 酶,它由每个同六聚体组成,每个单体含有一个 N 端结构域(N 域);两个 ATP 酶结构域,D1 和 D2;以及一个无序的 C 端区域。关于 N 域或 C 端区域在 p97 ATP 酶循环中的作用知之甚少。在与骨 Paget 病和额颞叶痴呆相关的 p97 相关人类疾病包涵体肌病中,大多数错义突变位于 N 域 D1 界面。基于结构的预测表明,这种突变会影响 N 域与 D1 的相互作用。在这里,我们测试了十个主要的与骨 Paget 病和额颞叶痴呆相关的包涵体肌病相关突变体的 ATP 酶活性,发现所有突变体的活性都比野生型高,其中一个突变体 p97(A232E)的活性高 3 倍。进一步对 p97(A232E)进行突变显示,ATP 酶活性的增加是通过 D2 介导的,需要 N 域和灵活的 ND1 接头。将 N 域锁定在 D1 共面位置的二硫键突变可可逆地消除 ATP 酶活性。p97(A232E)的 cryo-EM 重建表明 N 域是灵活的。去除 C 端区域也会降低 ATP 酶活性。总之,我们的数据表明,N 域相对于 D1-D2 六聚体的构象直接与 ATP 水解相关,并且 C 端区域是六聚体稳定性所必需的。这使我们提出了一个模型,其中 N 域采用两种构象之一:与 ATP 水解兼容的灵活构象或无活性的共面构象。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a50/3318706/ead54e23d358/zbc0131200740006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a50/3318706/ab67c866b4f7/zbc0131200740001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a50/3318706/c8861d455015/zbc0131200740002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a50/3318706/68daa9cb97a1/zbc0131200740003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a50/3318706/11c81195e173/zbc0131200740004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a50/3318706/b48bb34e29be/zbc0131200740005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a50/3318706/ead54e23d358/zbc0131200740006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a50/3318706/ab67c866b4f7/zbc0131200740001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a50/3318706/c8861d455015/zbc0131200740002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a50/3318706/68daa9cb97a1/zbc0131200740003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a50/3318706/11c81195e173/zbc0131200740004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a50/3318706/b48bb34e29be/zbc0131200740005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a50/3318706/ead54e23d358/zbc0131200740006.jpg

相似文献

1
The role of the N-domain in the ATPase activity of the mammalian AAA ATPase p97/VCP.N 结构域在哺乳动物 AAA ATPase p97/VCP 的 ATP 酶活性中的作用。
J Biol Chem. 2012 Mar 9;287(11):8561-70. doi: 10.1074/jbc.M111.302778. Epub 2012 Jan 23.
2
Hereditary inclusion body myopathy-linked p97/VCP mutations in the NH2 domain and the D1 ring modulate p97/VCP ATPase activity and D2 ring conformation.遗传性包涵体肌病相关的p97/VCP在氨基结构域和D1环中的突变调节p97/VCP的ATP酶活性和D2环构象。
Mol Cell Biol. 2009 Aug;29(16):4484-94. doi: 10.1128/MCB.00252-09. Epub 2009 Jun 8.
3
A novel ATP-dependent conformation in p97 N-D1 fragment revealed by crystal structures of disease-related mutants.通过疾病相关突变体的晶体结构揭示 p97 N-D1 片段中的一种新型 ATP 依赖构象。
EMBO J. 2010 Jul 7;29(13):2217-29. doi: 10.1038/emboj.2010.104. Epub 2010 May 28.
4
D1 ring is stable and nucleotide-independent, whereas D2 ring undergoes major conformational changes during the ATPase cycle of p97-VCP.D1环是稳定的且不依赖核苷酸,而D2环在p97-VCP的ATP酶循环过程中会发生主要的构象变化。
J Biol Chem. 2003 Aug 29;278(35):32784-93. doi: 10.1074/jbc.M303869200. Epub 2003 Jun 13.
5
Specific inhibition of p97/VCP ATPase and kinetic analysis demonstrate interaction between D1 and D2 ATPase domains.对p97/VCP ATP酶的特异性抑制及动力学分析表明D1和D2 ATP酶结构域之间存在相互作用。
J Mol Biol. 2014 Jul 29;426(15):2886-99. doi: 10.1016/j.jmb.2014.05.022. Epub 2014 May 27.
6
Valosin-Containing Protein (VCP)/p97 Oligomerization.包含缬氨酸蛋白(VCP)/ p97 寡聚化。
Subcell Biochem. 2024;104:485-501. doi: 10.1007/978-3-031-58843-3_18.
7
Altered intersubunit communication is the molecular basis for functional defects of pathogenic p97 mutants.构象改变的亚基间通讯是致病性 p97 突变体功能缺陷的分子基础。
J Biol Chem. 2013 Dec 20;288(51):36624-35. doi: 10.1074/jbc.M113.488924. Epub 2013 Nov 6.
8
Role of the D1-D2 Linker of Human VCP/p97 in the Asymmetry and ATPase Activity of the D1-domain.人VCP/p97的D1-D2连接体在D1结构域的不对称性和ATP酶活性中的作用
Sci Rep. 2016 Jan 28;6:20037. doi: 10.1038/srep20037.
9
Multifunctional roles of the conserved Arg residues in the second region of homology of p97/valosin-containing protein.p97/含缬酪肽蛋白同源性第二区域中保守精氨酸残基的多功能作用。
J Biol Chem. 2005 Dec 9;280(49):40515-23. doi: 10.1074/jbc.M509636200. Epub 2005 Oct 10.
10
Nucleocytoplasmic shuttling of valosin-containing protein (VCP/p97) regulated by its N domain and C-terminal region.含缬酪肽蛋白(VCP/p97)的核质穿梭受其N结构域和C末端区域调控。
Biochim Biophys Acta. 2015 Jan;1853(1):222-32. doi: 10.1016/j.bbamcr.2014.10.019. Epub 2014 Oct 30.

引用本文的文献

1
Utilization of CoRDS registry to monitor quality of life in patients with VCP multisystem proteinopathy.利用CoRDS注册系统监测VCP多系统蛋白病患者的生活质量。
Orphanet J Rare Dis. 2025 Apr 15;20(1):178. doi: 10.1186/s13023-025-03567-w.
2
Elevated VCP ATPase Activity Correlates With Disease Onset in Multisystem Proteinopathy-1.升高的VCP ATP酶活性与多系统蛋白病1的疾病发作相关。
Neurol Genet. 2024 Sep 12;10(5):e200191. doi: 10.1212/NXG.0000000000200191. eCollection 2024 Oct.
3
Mechanism of allosteric inhibition of human p97/VCP ATPase and its disease mutant by triazole inhibitors.

本文引用的文献

1
Cellular functions of Ufd2 and Ufd3 in proteasomal protein degradation depend on Cdc48 binding.Ufd2 和 Ufd3 在蛋白酶体蛋白降解中的细胞功能依赖于 Cdc48 的结合。
Mol Cell Biol. 2011 Apr;31(7):1528-39. doi: 10.1128/MCB.00962-10. Epub 2011 Jan 31.
2
Enhanced ATPase activities as a primary defect of mutant valosin-containing proteins that cause inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia.突变型含缬氨酸蛋白的主要缺陷为增强的 ATP 酶活性,这种缺陷导致与骨 Paget 病和额颞叶痴呆相关的包涵体肌病。
Genes Cells. 2010 Aug;15(8):911-22. doi: 10.1111/j.1365-2443.2010.01428.x. Epub 2010 Jul 5.
3
三唑类抑制剂对人p97/VCP ATP酶及其疾病突变体的变构抑制机制
Commun Chem. 2024 Aug 9;7(1):177. doi: 10.1038/s42004-024-01267-3.
4
Valosin-Containing Protein (VCP)/p97 Oligomerization.包含缬氨酸蛋白(VCP)/ p97 寡聚化。
Subcell Biochem. 2024;104:485-501. doi: 10.1007/978-3-031-58843-3_18.
5
Valosin-Containing Protein (VCP): A Review of Its Diverse Molecular Functions and Clinical Phenotypes.泛素结合酶 VCP(Valosin-Containing Protein):分子功能与临床表型多样性综述。
Int J Mol Sci. 2024 May 22;25(11):5633. doi: 10.3390/ijms25115633.
6
Clinical Classification of Variants in the Valosin-Containing Protein Gene Associated With Multisystem Proteinopathy.与多系统蛋白病相关的含缬酪肽蛋白基因变异的临床分类
Neurol Genet. 2023 Aug 15;9(5):e200093. doi: 10.1212/NXG.0000000000200093. eCollection 2023 Oct.
7
Novel Variants in the Gene Causing Multisystem Proteinopathy 1.导致多系统蛋白病 1 的 基因中的新型变异。
Genes (Basel). 2023 Mar 8;14(3):676. doi: 10.3390/genes14030676.
8
Compounds activating VCP D1 ATPase enhance both autophagic and proteasomal neurotoxic protein clearance.化合物激活 VCP D1 ATPase 可增强自噬和蛋白酶体神经毒性蛋白清除。
Nat Commun. 2022 Jul 16;13(1):4146. doi: 10.1038/s41467-022-31905-0.
9
A clinicopathologic study of malignancy in VCP-associated multisystem proteinopathy.VCP 相关多系统蛋白病中恶性肿瘤的临床病理研究。
Orphanet J Rare Dis. 2022 Jul 15;17(1):272. doi: 10.1186/s13023-022-02403-9.
10
Autophagy Dysfunction in ALS: from Transport to Protein Degradation.肌萎缩侧索硬化症中的自噬功能障碍:从运输到蛋白质降解。
J Mol Neurosci. 2022 Jul;72(7):1456-1481. doi: 10.1007/s12031-022-02029-3. Epub 2022 Jun 16.
A novel ATP-dependent conformation in p97 N-D1 fragment revealed by crystal structures of disease-related mutants.
通过疾病相关突变体的晶体结构揭示 p97 N-D1 片段中的一种新型 ATP 依赖构象。
EMBO J. 2010 Jul 7;29(13):2217-29. doi: 10.1038/emboj.2010.104. Epub 2010 May 28.
4
Imbalances in p97 co-factor interactions in human proteinopathy.人蛋白病变中 p97 辅助因子相互作用的失衡。
EMBO Rep. 2010 Jun;11(6):479-85. doi: 10.1038/embor.2010.49. Epub 2010 Apr 23.
5
Structural and functional implications of phosphorylation and acetylation in the regulation of the AAA+ protein p97.磷酸化和乙酰化在 AAA+ 蛋白 p97 调控中的结构和功能意义。
Biochem Cell Biol. 2010 Feb;88(1):41-8. doi: 10.1139/o09-128.
6
A conserved unfoldase activity for the p97 AAA-ATPase in proteasomal degradation.蛋白酶体降解过程中p97 AAA-ATP酶的保守解折叠酶活性。
J Mol Biol. 2009 Dec 11;394(4):732-46. doi: 10.1016/j.jmb.2009.09.050. Epub 2009 Sep 24.
7
Hereditary inclusion body myopathy-linked p97/VCP mutations in the NH2 domain and the D1 ring modulate p97/VCP ATPase activity and D2 ring conformation.遗传性包涵体肌病相关的p97/VCP在氨基结构域和D1环中的突变调节p97/VCP的ATP酶活性和D2环构象。
Mol Cell Biol. 2009 Aug;29(16):4484-94. doi: 10.1128/MCB.00252-09. Epub 2009 Jun 8.
8
Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia.含缬酪肽蛋白病:伴有骨Paget病和额颞叶痴呆的包涵体肌病。
Neuromuscul Disord. 2009 May;19(5):308-15. doi: 10.1016/j.nmd.2009.01.009. Epub 2009 Apr 19.
9
A novel mutation in the VCP gene (G157R) in a German family with inclusion-body myopathy with Paget disease of bone and frontotemporal dementia.在一个患有伴有骨Paget病和额颞叶痴呆的包涵体肌病的德国家庭中,VCP基因出现一种新的突变(G157R)。
Muscle Nerve. 2009 Mar;39(3):389-91. doi: 10.1002/mus.21225.
10
VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder.与肌病、骨佩吉特病和额颞叶痴呆相关的VCP病:一种独特疾病的综述
Biochim Biophys Acta. 2008 Dec;1782(12):744-8. doi: 10.1016/j.bbadis.2008.09.003. Epub 2008 Sep 18.